Manufacturer record
Micro Labs Limited Unit-Iii: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Micro Labs Limited Unit-Iii (Puducherry) was declared Not of Standard Quality in February 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MXDY0005, Moxonidine Tablets BP (0.3 mg) (exp May 2025). RDTL Chandigarh (CDSCO lab) found it not of standard quality: Dissolution. Listed in the February 2024 alert.
Records by type
1 record linked to Micro Labs Limited Unit-Iii in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Moxonidine Tablets BP (0.3 mg) | Batch MXDY0005Mfg Jun 2022 · Exp May 2025 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Feb 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.